SpectraCure AB (2OK) Stock Statistics & Valuation Metrics

SpectraCure AB has a market cap or net worth of €8.88M. The enterprise value is €114.63M.

SpectraCure AB has 401,334,320 shares outstanding. The number of shares has decreased by -2.65% in one year.

SpectraCure AB’s return on equity (ROE) is -0.22 and return on invested capital (ROIC) is -20.59%.

The current PE Ratio of SpectraCure AB is -10.77. SpectraCure AB’s PEG ratio is -0.17.

In the last 12 months, SpectraCure AB had revenue of 19.53M and earned -23.00M in profits. Earnings per share was -0.24.

In the last 12 months, operating cash flow was -23.67M and capital expenditures -14.46M, giving a free cash flow of -38.13M billion.

SpectraCure AB pays an annual dividend of ―, resulting in a dividend yield of ―

SpectraCure AB upcoming earnings date is Aug 21, 2025, Before Open (Confirmed).

SpectraCure AB as a current ratio of 1.93, with Debt / Equity ratio of 4.55%

In the past 12 months, SpectraCure AB has paid 7.00K in taxes.

SpectraCure AB EV to EBITDA ratio is -11.49, with an EV/FCF ratio of -6.32.

SpectraCure AB has €8.09M in cash and marketable securities with kr4.58M in debt, giving a net cash position of -€3.51M billion.

Gross margin is 0.00%, with operating margin of -118.05%, and net profit margin of -117.78%.

The average price target for SpectraCure AB is €0.04, which is 11.43% higher than the current price. The consensus rating is Hold